Log in to save to my catalogue

Characterization of Sigma-2 Receptor—Specific Binding Sites Using [[sup.3]H]DTG and [[sup.125]I]RHM-...

Characterization of Sigma-2 Receptor—Specific Binding Sites Using [[sup.3]H]DTG and [[sup.125]I]RHM-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A746370633

Characterization of Sigma-2 Receptor—Specific Binding Sites Using [[sup.3]H]DTG and [[sup.125]I]RHM-4

About this item

Full title

Characterization of Sigma-2 Receptor—Specific Binding Sites Using [[sup.3]H]DTG and [[sup.125]I]RHM-4

Publisher

MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2022-12, Vol.15 (12)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

The sigma-2 receptor/transmembrane protein 97 (σ2R/TMRM97) is a promising biomarker of tumor proliferation and a target for cancer therapy. [[sup.3] H]DTG has been used to evaluate σ2R/TMEM97 binding affinity in compound development studies. However, [[sup.3] H]DTG has equal and moderate binding affinities to both sigma 1 receptor (σ1R) and σ2R/TME...

Alternative Titles

Full title

Characterization of Sigma-2 Receptor—Specific Binding Sites Using [[sup.3]H]DTG and [[sup.125]I]RHM-4

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A746370633

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A746370633

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph15121564

How to access this item